Skip to main content

Evidence-based Anticancer Materia Medica for Cervical Cancer

  • Chapter
  • First Online:

Part of the book series: Evidence-based Anticancer Complementary and Alternative Medicine ((ACAM,volume 2))

Abstract

Carcinoma of the cervix is the second most common malignant neoplasia among women, following breast cancer. Approximately 500,000 new cases of cervix cancer are diagnosed worldwide each year. Along with conventional chemotherapeutic or surgery treatment, there is an increased interest in alternative treatment modalities that include complementary and alternative medicine (CAM). In this chapter, we have reviewed the literature related with the herbs, herbal formulations and phytochemical constituents that act specifically inhibiting the neoplasia of the cervix. Large amount of data is available on in vitro anticancer effects of different herbal preparations and isolated bioactive compounds on cervical cancer cells, evaluating the mechanisms that underlie their effects. Turmeric, mistletoe and green tea are representative plants that exert anticancer effects. Despite of large amount of data on in vitro anticancer effects of different herbal preparations and isolated bioactive compounds on cervical cancer cells, only few clinical studies have been performed in humans. Only paclitaxel, irinotecan, and vinorelbine (chemotherapeutic agents of plant origin) have been investigated in an ongoing a Phase III clinical trials or already successfully applied as a part of conventional chemotherapeutic regiments for cervical cancer. The continued popularity of herbal remedies worldwide suggests that evidence-based research in this field, as well as information regarding the potential efficacy and safety of phytochemical constituents in herbs is essential, particularly when CAM is used in combination with other drugs.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–398

    PubMed  CAS  Google Scholar 

  • Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE et al (2003) Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 12:383–390

    PubMed  Google Scholar 

  • Ammon HP, Wahl MA (1991) Pharmacology of Curcuma longa. Planta Med 57:1–7

    PubMed  CAS  Google Scholar 

  • Antonia S, Mule JJ, Weber JS (2004) Current developments of immunotherapy in the clinic. Curr Opin Immunol 16:130–136

    PubMed  CAS  Google Scholar 

  • Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, Vermeulen NP (2007) Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 235:83–91

    PubMed  CAS  Google Scholar 

  • Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG (2008) Bulten Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. J Obstet Gynecol 111:167–177

    Google Scholar 

  • Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BB (2004) Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol 67:353–364

    PubMed  CAS  Google Scholar 

  • Barnes J, Anderson LA, Phillipson DJ (2007) Herbal medicines. Pharmaceutical Press, London/Chicago

    Google Scholar 

  • Bar-Sela G, Epelbaum R, Schaffer M (2010) Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17:190–197

    PubMed  CAS  Google Scholar 

  • Beijnen JH, Schellens JH (2004) Drug interactions in oncology. Lancet Oncol 5:489–496

    PubMed  CAS  Google Scholar 

  • Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P et al (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78:123–129

    PubMed  CAS  Google Scholar 

  • Bernardi M, D’Intino PE, Trevisani F, Cantelli-Forti G, Raggi MA, Turchetto E et al (1994) Effects of prolonged ingestion of graded doses of liquorice by healthy volunteers. Life Sci 55:863–872

    PubMed  CAS  Google Scholar 

  • Bhavani Shankar TN, Shantha NV, Ramesh HP (1980) Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol 18:73–75

    Google Scholar 

  • Blumenthal M, Goldberg A, Brinckmann J (eds) (2000) Herbal medicine: expanded Commission E monographs. Integrative Medicine Communications, Austin

    Google Scholar 

  • Braun L, Cohen M (2007) Herbs & natural supplements: an evidence-based guide. Elsevier Australia, Marrickville

    Google Scholar 

  • Brenner DE, Gescher AJ (2005) Cancer chemoprevention: lessons learned and future directions. Br J Cancer 93:735–739

    PubMed  CAS  Google Scholar 

  • Brignall MS (2001) Prevention and treatment of cancer with indole-3-carbinol. Altern Med Rev 6:580–589

    PubMed  CAS  Google Scholar 

  • Brinker F (1998) Herb contraindications and drug interactions. Eclectic Medical Publications, Sandy

    Google Scholar 

  • Budzinski JW, Foster BC, Vandenhoek S, Arnason JT (2000) An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7:273–282

    PubMed  CAS  Google Scholar 

  • Bussing A, Stumpf C, Troger W, Schietzel M (2007) Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts. Anticancer Res 27:2903–2910

    PubMed  CAS  Google Scholar 

  • Cao W, Li XQ, Wang X, Fan HT, Zhang XN, Hou Y et al (2010) A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway. Phytomedicine 17:598–605

    PubMed  CAS  Google Scholar 

  • Caponigro F, Basile M, De Rosa V, Normanno N (2005) New drugs in cancer therapy. Anticancer Drugs 16:211–221

    PubMed  CAS  Google Scholar 

  • Cassileth BR (1999) Evaluating complementary and alternative therapies for cancer patients. CA: Canc J Clin 49:362–375

    CAS  Google Scholar 

  • Cassileth BK, Yeung S, Gubili J (2008) Herbs and other botanicals in cancer patient care. Curr Treat Options Oncol 9:109–116

    PubMed  Google Scholar 

  • Chainani-Wu N (2003) Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med 9:161–168

    PubMed  Google Scholar 

  • Chamberlain TJ (1970) Licorice poisoning, pseudoaldosteronism, heart failure. JAMA 213:343

    Google Scholar 

  • Chan HT, Chan C, Ho JW (2003a) Inhibition of glycyrrhizic acid on aflatoxin B1-induced cytotoxicity in hepatoma cells. Toxicology 188:211–217

    PubMed  CAS  Google Scholar 

  • Chan MM, Fong D, Soprano KJ, Holmes WF, Heverling H (2003b) Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 194:63–70

    PubMed  CAS  Google Scholar 

  • Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS et al (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–2900

    PubMed  CAS  Google Scholar 

  • Chung JH, Choi DH, Choi JS (2009) Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 30:90–93

    PubMed  CAS  Google Scholar 

  • Conn JW, Rovner DR, Cohen EL (1968) Licorice-induced pseudoaldosteronism. Hypertension, hypokaelemia, aldosteronopenia and suppressed plasma renin activity. JAMA 205:492–496

    PubMed  CAS  Google Scholar 

  • Correa-Velez I, Clavarino A, Eastwood H (2005) Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 8(5):953–961

    PubMed  Google Scholar 

  • Corsi FM, Galgani S, Gasparini C, Giacanelli M, Piazza G (1983) Acute hypokalemic myopathy due to chronic licorice ingestion: report of a case. Ital J Neurol Sci 4:493–497

    PubMed  CAS  Google Scholar 

  • de Moura MD, de Sousa e Silva J, de Oliveira RA, Diniz MF, Barbosa-Filho JM (2002) Natural products reported as potential inhibitors of uterine cervical neoplasia. Acta Farm Bonaerense 21:67–74

    Google Scholar 

  • Del Priore G, Gudipudi DK, Montemarano N, Restivo AM, Malanowska-Stega J, Arslan AA (2010) Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 116:464–467

    PubMed  Google Scholar 

  • Duarte-Franco E, Eduardo MD, Franko L (2001) Determinants of patient survival in cervical cancer: an overview. J Gynecol Oncol 6:173–183

    Google Scholar 

  • Dy G, Bekele L, Hanson L, Furth A, Mandrekar S, Sloan J et al (2004) Complementaty and alternative medicine use by patients enrolled onto Phase I clinical trials. J Clin Oncol 22:4810–4815

    PubMed  Google Scholar 

  • Elshaikh M, Ljungman M, Ten Haken R, Lichter AS (2006) Advances in radiation oncology. Annu Rev Med 57:19–31

    PubMed  CAS  Google Scholar 

  • Eriksson JW, Carlberg B, Hillorn V (1999) Life-threatening ventricular tachycardia due to liquorice-induced hypokalemia. J Intern Med 245:307–310

    PubMed  CAS  Google Scholar 

  • Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T et al (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med 7:25

    PubMed  Google Scholar 

  • Farese RV Jr, Biglieri EG, Shackleton CH, Irony I, Gomez-Fontes R (1991) Licorice-induced hypermineralocorticoidism. N Engl J Med 325:1223–1227

    PubMed  Google Scholar 

  • Fellmer Ch, Fellmer KE (1966) Nachbehandlung bestrahlter Genitalkarzinome mit dem Viscum-album-Präparat “Iscador”. Krebsarzt 21:174–185

    Google Scholar 

  • Finall AI, McIntosh SA, Thompson WD (2006) Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract. BMJ 333:1293–1294

    PubMed  CAS  Google Scholar 

  • Fleming T (ed) (2000) PDR for herbal medicines. Medical Economics Company, Montvale

    Google Scholar 

  • Forslund T, Fyhrquist F, Froseth B, Tikkanen I (1989) Effects of licorice on plasma atrial natriuretic peptide in healthy volunteers. J Intern Med 225:95–99

    PubMed  CAS  Google Scholar 

  • Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K et al (1999) Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220:225–228

    PubMed  CAS  Google Scholar 

  • Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG et al (2009) Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 113:5927–5937

    PubMed  CAS  Google Scholar 

  • Gorter RW, van Wiley M, Stoss M, Wollina U (1998) Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am J Health Ther 5:181–187

    CAS  Google Scholar 

  • Grossarth-Maticek R, Kiene H, Baumgartner S, Ziegler R (2001) Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 7:57–78

    PubMed  CAS  Google Scholar 

  • Gururaj AE, Belakavadi M, Venkatesh DA, Marmé D, Salimath BP (2002) Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Bioph Res Co 297:934–942

    CAS  Google Scholar 

  • Hata M, Sasaki E, Ota M, Fujimoto K, Yajima J, Shichida T et al (1997) Allergic contact dermatitis from curcumin (turmeric). Contact Dermatitis 36:107–108

    PubMed  CAS  Google Scholar 

  • Hu Z, Yang X, Ho PCL, Chan SY, Heng PWS, Chan E et al (2005) Herb-drug interactions. Drugs 65:1239–1282

    PubMed  CAS  Google Scholar 

  • Javvadi P, Segan AT, Tuttle SW, Koumenis C (2008) The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73:1491–1501

    PubMed  CAS  Google Scholar 

  • Jeong HG, You HJ, Park SJ, Moon AR, Chung YC, Kang SK et al (2002) Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol Res 46:221–227

    PubMed  CAS  Google Scholar 

  • Jhanwar YS, Divgi C (2005) Current status of therapy of solid tumors. J Nucl Med 46:141–150

    Google Scholar 

  • Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS et al (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during promotion/progression stage of colon cancer. Cancer Res 59:597–601

    PubMed  CAS  Google Scholar 

  • Kelloff GJ, Boone CW, Steele VE, Crowell JA, Lubet R, Sigman CC (1994) Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Cancer Res 54:2015s–2024s

    PubMed  CAS  Google Scholar 

  • Kent UM, Aviram M, Rosenblat M, Hollenberg PF (2002) The licorice root derived isoflavan glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6, and 2C9. Drug Metab Dispos 30:709–715

    PubMed  CAS  Google Scholar 

  • Kienle GS, Glockmann A, Schink M, Kiene HJ (2009) Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. Exp Clin Cancer Res 28:79

    Google Scholar 

  • Konić-Ristić A, Šavikin K, Zdunić G, Janković T, Juranić Z, Menković N, Stanković I (2011) Biological activity and chemical composition of different berry juices. Food Chem 125:1412–1417

    Google Scholar 

  • Koppikar SJ, Choudhari AS, Suryavanshi SA, Kumari S, Chattopadhyay S, Kaul-Ghanekar R (2010) Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer 10:210

    PubMed  Google Scholar 

  • Kundaković T, Stanojković T, Juranić Z, Kovacević N (2005) Cytotoxic and antioxidant activity of Achillea alexandri-regis. Pharmazie 60:319–320

    PubMed  Google Scholar 

  • Kundaković T, Stanojković T, Juranić Z, Kovacević N (2006) Cytotoxicity in vitro of naphthazarin derivatives from Onosma arenaria. Phytother Res 20:602–604

    PubMed  Google Scholar 

  • Kundu JK, Surh YJ (2004) Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets. Mutat Res 555:65–80

    PubMed  CAS  Google Scholar 

  • Lin SH, Yang SS, Chau T, Halperin ML (2003) An unusual cause of hypokalemic paralysis: chronic licorice ingestion. Am J Med Sci 325:153–156

    PubMed  Google Scholar 

  • Maier G, Fiebig HH (2002) Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro. Anticancer Drugs 13:373–379

    PubMed  CAS  Google Scholar 

  • Miner TJ (2005) Palliative surgery for advanced cancer: lessons learned in patient selection and outcome assessment. Am J Clin Oncol 28:411–414

    PubMed  Google Scholar 

  • Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N et al (2000) Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405–10412

    PubMed  CAS  Google Scholar 

  • Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S et al (2006) Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 316:1369–1377

    PubMed  CAS  Google Scholar 

  • Nabekura T, Yamaki T, Ueno K, Kitagawa S (2008) Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 62:867–873

    PubMed  CAS  Google Scholar 

  • Noguchi M, Yokoyama M, Watanabe S, Uchiyama M, Nakao Y, Hara K et al (2006) Inhibitory effect of the tea polyphenol, (−)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines. Cancer Lett 234:135–142

    PubMed  CAS  Google Scholar 

  • Patel D, Shukla S, Gupta S (2007) Apigenin and cancer chemoprevention: progress, potential and promise (Review). Int J Oncol 30:233–245

    PubMed  CAS  Google Scholar 

  • Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J (2001) The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 33:125–147

    PubMed  CAS  Google Scholar 

  • Portalupi E (1995) Neoadjuvant treatment in HPV-related CIN with Mistletoe preparation (Iscador). Dissertation Universität Pavia 1991/1992

    Google Scholar 

  • Prucksunand C, Indrasukhsri B, Leethochawalit M, Hungspreugs K (2001) Phase II clinical trial on effect of the long turmeric (Curcuma longa Linn) on healing of peptic ulcer. Southeast Asian J Trop Med Public Health 32:208–215

    PubMed  CAS  Google Scholar 

  • Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G et al (2000) Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res 20:2653–2658

    PubMed  CAS  Google Scholar 

  • Robinson DM (2003) Anaphylaxis to turmeric. J Allergy Clin 111:S100

    Google Scholar 

  • Rosell S, Samuelsson G (1966) Effect of mistletoe viscotoxin and phoratoxin on blood circulation. Toxicon 4:107–110

    PubMed  CAS  Google Scholar 

  • Russo S, Mastropasqua M, Mosetti MA, Persegani C, Paggi A (2000) Low doses of licorice can induce hypertension encephalopathy. Am J Nephrol 20:145–148

    PubMed  CAS  Google Scholar 

  • Sadeghi-Aliabadi H, Ghasemic N, Fatahia A (2006) Cytotoxic effects of Iranian mistletoe extract on a panel of cancer cells. Iranian J Pharm Sci 2:157–162

    Google Scholar 

  • Sagar SM, Yance D, Wong RK (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol 13:14–26

    PubMed  CAS  Google Scholar 

  • Samuelsson G (1966) Screening of plants of the family Loranthaceae for toxic proteins. Acta Pharm Suec 3:353–362

    PubMed  CAS  Google Scholar 

  • Sasieni P (2006) Chemoprevention of cervical cancer. Best Pract Res Clin Obstet Gynaecol 20:295–305

    PubMed  Google Scholar 

  • Šavikin K, Zdunić G, Janković T, Stanojković T, Juranić Z, Menković N (2009) In vitro cytotoxic and antioxidative activity of Cornus mas and Cotinus coggygria. Nat Prod Res 23:1731–1739

    PubMed  Google Scholar 

  • Schulz V, Hansel R, Tyler V (2001) Rational phytotherapy: a physician’s guide. Springer, New York

    Google Scholar 

  • Sen S, Sharma H, Singh N (2005) Curcumin enhances vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 331:1245–1252

    PubMed  CAS  Google Scholar 

  • Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM et al (2001) Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7:1894–1900

    PubMed  CAS  Google Scholar 

  • Shin SC, Choi JS (2009) Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 20:584–588

    PubMed  CAS  Google Scholar 

  • Shintani S, Murase H, Tsukagoshi H, Shiigai T (1992) Glycyrrhizin (licorice)-induced hypokalemic myopathy. Eur Neurol 32:44–51

    PubMed  CAS  Google Scholar 

  • Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S (2001) Licorice-induced rise in blood pressure: a linear dose-response relation- ship. J Hum Hypertens 15:549–552

    PubMed  CAS  Google Scholar 

  • Singh S, Aggarwal BB (1995) Activation of transcription factor NF-κB is suppressed by curcumin (diferuloyl-methane). J Biol Chem 270:24995–25000

    PubMed  CAS  Google Scholar 

  • Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ (2002) Dietary curcumin inhibits chemotheraphy induced apoptosis in models of human breast cancer. Cancer Res 62:3868–3875

    PubMed  CAS  Google Scholar 

  • Stanojković TP, Konić-Ristić A, Juranić ZD, Savikin K, Zdunić G, Menković N et al (2010) Cytotoxic and cell cycle effects induced by two herbal extracts on human cervix carcinoma and human breast cancer cell lines. J Med Food 13:291–297

    PubMed  Google Scholar 

  • Steinmetz KA, Potter JD (1996) Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96:1027–1039

    PubMed  CAS  Google Scholar 

  • Stević T, Šavikin K, Zdunić G, Stanojković T, Juranić Z, Janković T et al (2010) Antioxidant, cytotoxic, and antimicrobial activity of Alnus incana (L.) ssp. incana Moench and A. viridis (Chaix) DC ssp. viridis extracts. J Med Food 13:700–704

    PubMed  Google Scholar 

  • Stirpe F, Legg RF, Onyon LJ, Ziska P, Franz H (1980) Inhibition of protein synthesis by a toxic lectin from Viscum album L. (mistletoe). Biochem J 190:843–845

    PubMed  CAS  Google Scholar 

  • Sugiyama T, Sadzuka Y (2004) Theanine, a specific glutamate derivative in green tea, reduces the adverse reactions of doxorubicin by changing the glutathione level. Cancer Lett 212:177–184

    PubMed  CAS  Google Scholar 

  • Takara K, Horibe S, Obata Y, Yoshikawa E, Ohnishi N, Yokoyama T (2005) Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells. Biol Pharm Bull 28:138–142

    PubMed  CAS  Google Scholar 

  • Taylor JR, Wilt VM (1999) Probable antagonism of warfarin by green tea. Ann Pharmacother 33:426–428

    PubMed  CAS  Google Scholar 

  • Thaloor D, Singh AK, Sidhu GS, Prasad PV, Kleinman HK, Maheshwari RK (1998) Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9:305–312

    PubMed  CAS  Google Scholar 

  • Thani W, Vallisuta O, Siripong P, Ruangwises N (2010) Anti-proliferative and antioxidative activities of Thai noni/Yor (Morinda citrifolia Linn.) leaf extract. Southeast Asian J Trop Med Public Health 41:482–489

    PubMed  Google Scholar 

  • Tierney B, Westin SN, Schlumbrecht MP, Ramirez PT (2010) Early cervical neoplasia: advances in screening and treatment modalities. Clin Adv Hemat Oncol 8:8

    Google Scholar 

  • Trifunović S, Vajs V, Juranić Z, Žižak Ž, Tešević V, Macura S et al (2006) Cytotoxic constituents of Achillea clavennae from Montenegro. Phytochemistry 67:887–893

    PubMed  Google Scholar 

  • van-den Bosch AE, van-der Klooster JM, Zuidgeest DM, Ouwendijk RJ, Dees A (2005) Severe hypokalaemic paralysis and rhabdomyolysis due to ingestion of liquorice. Neth J Med 63:146–148

    PubMed  Google Scholar 

  • Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286

    PubMed  Google Scholar 

  • Vizcaino PA, Moreno V, Bosch XF, Munoz N, Barros-Dios XM, Parkin MD (1998) International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75:536–545

    PubMed  CAS  Google Scholar 

  • Vučković I, Lj V, Stešević D, Radulović S, Lazić M, Milosavljević S (2010) Cytotoxic guaianolide from Anthemis segetalis (Asteraceae). Phytother Res 24:225–227

    PubMed  Google Scholar 

  • Wang Y, Zhang H, Holmgren A, Tian W, Zhong L (2008) Inhibitory effect of green tea extract and (−)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Oncol Rep 20:1479–1487

    PubMed  CAS  Google Scholar 

  • Wu Z, Wu LJ, Li LH, Tashiro S, Onodera S, Ikejima T (2004) Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis. J Asian Nat Prod Res 6:155–166

    PubMed  CAS  Google Scholar 

  • Xaio P (1983) Recent developments on medicinal plants in China. J Ethnopharmacol 7:95–109

    PubMed  CAS  Google Scholar 

  • Yu M, Deng PX, Qi C, Deng B, Zhao ZZ, Wong V et al (2009) Adjuvant phytotherapy in the treatment of cervical cancer: a systematic review and meta-analysis. J Altern Complement Med 15:1347–1353

    Google Scholar 

  • Zhang W, Tan TM, Lim LY (2007) Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 35:110–115

    PubMed  Google Scholar 

  • Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton J (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35–98

    PubMed  CAS  Google Scholar 

  • Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL et al (2002) Radiosensitizing and antiproliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 175:165–173

    PubMed  CAS  Google Scholar 

  • Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F (2010) Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer 20:617–624

    PubMed  Google Scholar 

Download references

Acknowledgment

The authors acknowledge the gratitude to the Ministry of Science and Technological Development of Serbia for financial support, project No. 46013.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katarina Šavikin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Stanojković, T., Konić-Ristić, A., Janković, T., Zdunić, G., Šavikin, K. (2012). Evidence-based Anticancer Materia Medica for Cervical Cancer. In: Cho, W. (eds) Materia Medica for Various Cancers. Evidence-based Anticancer Complementary and Alternative Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1983-5_7

Download citation

Publish with us

Policies and ethics